Brain scans reveal Dopamine's role in chronic pain

NCT ID NCT05285683

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores how dopamine, a brain chemical linked to motivation, influences chronic pain. Ten adults with chronic pain will receive two dopamine-boosting drugs (methylphenidate and carbidopa-levodopa) or a placebo, then undergo brain scans to measure changes in key pain-related areas. The goal is to understand the brain's pain signature, not to treat pain directly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

methylphenidate and carbidopa-levodopa

What this could lead to

If successful, this could reveal how dopamine influences chronic pain in the brain, pointing toward new treatment targets.

What could go wrong

This is a very small early-phase study with only 10 participants, focused on brain changes rather than pain relief, so results may not lead to treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Rochester Medical Center

    RECRUITING

    Rochester, New York, 14642, United States